Informed Consent in Clinical Trials

Informed Consent in Clinical Trials: Informed consent is an ongoing, voluntary process through which an eligible person receives understandable information and decides whether to participate in research.

Why professionals need this knowledge: A signed form alone does not prove that participants had time, capacity and freedom to make an informed choice.

Step 1: Explain purpose, procedures, foreseeable risks, benefits, alternatives, confidentiality, withdrawal and contact details in clear language.

Step 2: Check understanding, provide time for questions, address language and accessibility needs, and avoid undue influence.

Step 3: Document the process appropriately and assess whether new safety or protocol information requires renewed consent.

Worked example: A participant is recruited while waiting for routine treatment. The research team must make clear which care is standard and which activities are study-specific.

What to avoid: Rushing signatures, using unexplained technical jargon, enrolling before required approvals or treating consent as a one-time administrative event. An apparently neat form is not a substitute for reliable actions and sound judgement in the real workflow.

Records and audit trail: Approved consent versions, discussions, dates, language support and required re-consent decisions. Accurate records enable independent review and appropriate follow-up when concerns arise.

Try this exercise: Ask a colleague to explain a study's main risks and withdrawal rights using only the participant-facing document. Discuss the exercise with an appropriately qualified colleague before applying it to a live case.

Standards and references: ICH Good Clinical Practice principles, the approved protocol and relevant ethics and national regulations. This is educational material; the approved protocol, governing standard and local law take precedence.